Glumetza offers once-a-day dosing for type 2 diabetes patients

Gary Laustsen

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Glumetza offers once-a-day dosing for type 2 diabetes patients'. Together they form a unique fingerprint.